Published Date: 17 Feb 2023
China: Low-dose colchicine helps protect myocardium in surgery patients without CABG (coronary artery bypass graft).
Read Full NewsAn investigative inhaled formulation of the psychedelic mebufotenin is linked to significant improvements in depression symptoms compared to placebo, a phase 2b trial shows.
A biological computer using human neurons learns Doom within 1 week, highlighting rapid adaptive learning and potential advantages over traditional AI systems.
The findings could fill a treatment gap for patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC) who also carry TP53 mutations.
Both drugs increase overall and progression-free survival.
1.
Researchers have determined that malignancy hibernation will be the next front in the fight against breast cancer.
2.
Base-edited T-cell therapy offers additional hope for treating resistant leukemia.
3.
Women are more susceptible to the stress caused by inflation.
4.
According to the CAPTIVATE Study, fixed-duration ibrutinib plus venetoclax may be beneficial for patients with high-risk chronic lymphocytic leukemia.
5.
When Should Immunocompromised Individuals Receive a COVID Booster?
1.
The Benefits and Side Effects of Bortezomib in the Fight Against Cancer
2.
Surprising Symptoms of Prostate Cancer: What You Need to Know
3.
The Unseen Danger of Anal Cancer: How to Protect Yourself
4.
Precision to Personalization: Expanding Genetic Testing and Counseling in Oncology
5.
Understanding the Silent Threat: Unveiling Prostate Cancer Symptoms
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV
3.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V
5.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation